BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. (BioCryst) is a publicly traded biotechnology company. It is engaged in designing, optimizing and developing novel drugs that block enzymes causing cancer, viral infections and autoimmune diseases. The product portfolio of company includes Peramivir, Forodesine and BCX4208, a next generation PNP inhibitor for gout. It integrates the use of biology, crystallography, medicinal chemistry and computer modeling to use structure-based drug design effectively to discover and develop small molecule pharmaceuticals. BioCryst initiated structure-based drug design technologies in all the developmental efforts for design and development of drug candidates. The company is headquartered at Birmingham in Alabama, the US.

Street: 
2190
City: 
Birmingham
Postcode: 
35244
Federal State : 
United States
WebSite: 
www.biocryst.com
Fax: 
1-205-4444640

Company Index Score

Current Index Score Historical Index Score
  • BioCryst Pharmaceuticals, Inc. currently scores 50 % in the index.
  • BioCryst Pharmaceuticals, Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • BioCryst Pharmaceuticals, Inc. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets